Calidi Biotherapeutics, Inc. (CLDI) stock
CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
$0.56−0.04 (-7.07%)
Close on Nov 17, 2026Market cap $1.45MP/E –Yield –
Calidi Biotherapeutics total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Calidi Biotherapeutics's total debt was $45.00K at Jun 30, 2026. For fiscal 2025 it was $90.00K, down 97.2% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $90.00K | -97.2% |
| FY2024 | Dec 31, 2024 | $3.22M | +299.1% |
| FY2023 | Dec 31, 2023 | $807.00K | -85.1% |
| FY2022 | Dec 31, 2022 | $5.43M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $45.00K | -94.5% |
| Q1 FY2026 | Mar 31, 2026 | $23.00K | -98.0% |
| Q4 FY2025 | Dec 31, 2025 | $90.00K | -97.2% |
| Q3 FY2025 | Sep 30, 2025 | $472.00K | -84.8% |
| Q2 FY2025 | Jun 30, 2025 | $820.00K | -72.5% |
| Q1 FY2025 | Mar 31, 2025 | $1.16M | -72.7% |
| Q4 FY2024 | Dec 31, 2024 | $3.22M | +299.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.11M | -7.0% |
| Q2 FY2024 | Jun 30, 2024 | $2.98M | -45.0% |
| Q1 FY2024 | Mar 31, 2024 | $4.24M | – |
| Q4 FY2023 | Dec 31, 2023 | $807.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $3.35M | – |
| Q4 FY2022 | Dec 31, 2022 | $5.43M | – |
See a number that looks wrong?